Q Bio

Q Bio is building technology for the Physical of the Future that measures more, faster and cheaper about the human body, to enable proactive primary care for all. We're revolutionizing primary care with the first clinical digital twin platform, powered by breakthrough whole-body scanning technology, that highlights the most important changes in a person’s physiology for sharing with physicians and specialists anywhere in the world. Q Bio’s clinical digital twin platform, Gemini, is the first to capture and monitor comprehensive baseline patient health in a scalable virtual model. The Gemini Dashboard highlights the most important chemical and anatomical changes in an individual weighted by an individual’s lifestyle, genetic and medical history, that can be securely shared with physicians and specialists all over the world. Gemini is powered by the fastest, most accessible, whole body scanner developed: the Mark I. Self-driving and optimized for primary care, the Mark I can complete a whole-body scan in 15 minutes or less in an open space, without radiation, breath holds, or claustrophobia. Patient comfort is maximized with the option to sit, stand, or lie down, and real-time telemetry is displayed throughout. Q Bio has raised over $80M from world class investors including Andreessen Horowitz, Kaiser Foundation Hospitals, Khosla Ventures, Founders Fund, SciFi VC, and many more.